跳至主要内容
临床试验/2023-505153-41-00
2023-505153-41-00已完成1 期

Randomized, open-label, single dose, four-period, cross-over drug-drug interaction study comparing reference products Crestor 20 mg film coated tablets, Norvasc 10 mg tablets and Tritace 10 mg tablets administrated concomitantly versus each drug administrated alone in healthy male and female subjects under fasting conditions.

Adamed Pharma S.A.1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年7月4日最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
60
试验地点
1

研究概览

简要总结

暂无简介。

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

申办方类型
Pharmaceutical company
责任方
Principal Investigator
主要研究者

Pharmacokinetic Study Team

Scientific

Adamed Pharma S.A.

研究点 (1)

Loading locations...

相似试验

招募中
4 期
A single-dose, open-label, randomized, two-period, two-sequence, crossover pivotal bioequivalence study on two amoxicillin-clavulanic acid film-coated tablet formulations in healthy volunteers under fed conditions.
2025-521718-24-00Tarchominskie Zaklady Farmaceutyczne Polfa S.A.56
已完成
4 期
Randomized, open-label, single dose, two-period, two-treatment, cross-over bioequivalence study comparing test product Rivaroxaban/Acetylsalicylic acid, tablet, 2.5 mg/50 mg (given as two tablets) to reference product Xarelto 2.5 mg film-coated tablets (given as two tablets) and Aspirin® N 100 mg tablet in healthy male and female subjects under fasting conditions.
2024-513665-40-00Adamed Pharma S.A.62
招募中
4 期
An open-label, randomized, single-dose, two-period, two-treatment, crossover bioequivalence study with GP-IMP-001 in healthy male volunteers under fasting conditions.
2025-522921-37-00Gebro Pharma GmbH36
已完成
1 期
A randomized, open-label, single dose, cross-over study to evaluate the drug-drug interaction between Proscar 5 mg, film-coated tablets and Cialis 5 mg film-coated tablets when co-administered versus the administration of each product alone in healthy volunteers under fasting conditions. Study no. FIN-TAD-DDI-03-24
2024-510774-24-00Adamed Pharma S.A.30
已完成
1 期
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product Perampanel 12 mg film-coated tablets versus reference product Fycompa 12 mg film-coated tablets (Eisai GmbH) in healthy adult male and female subjects under fasting conditions.
2023-503345-59-00Laboratorios Cinfa S.A.36
Randomized, open-label, single dose, four-period,... | 临床试验